13.04.2005 20:13:00

CORRECTED: Embrex Announces First Quarter 2005 Financial Results Relea

CORRECTED: Embrex Announces First Quarter 2005 Financial Results Release and Conference Call


    Business Editors

    RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--April 13, 2005--Embrex(R), Inc., The In Ovo Company(R), (NASDAQ:EMBX) announced Embrex management intends to file its First Quarter 2005 Form 10-Q and issue its financial press release on Tuesday, May 3, 2005. Embrex's management, led by President and CEO Randall L. Marcuson, will further discuss these financial results in a conference call on Wednesday, May 4, at 11:00 a.m. EDT. To join the conference call, dial (877) 866-3175 (domestic and Canada), or (706) 679-7358 (international), identify Randall Marcuson as the conference leader.
    This call is being web cast by Thomson/CCBN and can be accessed at Embrex's web site at www.embrex.com. Click on the Investor Info button to access the link. The web cast is also being distributed over Thomson/CCBN's Investor Distribution Network to both institutional and individual investors. Individual investors can listen to the call through Thomson/CCBN's individual investor center at www.earnings.com or by visiting any of the investor sites in Thomson/CCBN's Individual Investor Network. Institutional investors can access the call via Thomson/CCBN's password-protected event management site, StreetEvents (www.streetevents.com).
    A telephone replay will be available from approximately 2 p.m. EDT May 4 to midnight EDT May 18 by dialing (800) 642-1687 (domestic and Canada), or (706) 645-9291 (international), conference ID 5447699.
    Embrex, Inc., The In Ovo Company(R), is an international agricultural biotechnology company engaged in the development of innovative in ovo (in the egg) solutions that meet the needs of today's global poultry industry.

    Embrex(R) and The In Ovo Company(R) are trademarks of Embrex, Inc.

--30--CE/cg*

CONTACT: Embrex, Inc. Ellen Moore, 919-314-2561

KEYWORD: NORTH CAROLINA INDUSTRY KEYWORD: ENVIRONMENT BIOTECHNOLOGY EARNINGS CONFERENCE CALLS SOURCE: Embrex, Inc.

Copyright Business Wire 2005

JETZT DEVISEN-CFDS MIT BIS ZU HEBEL 30 HANDELN
Handeln Sie Devisen-CFDs mit kleinen Spreads. Mit nur 100 € können Sie mit der Wirkung von 3.000 Euro Kapital handeln.
82% der Kleinanlegerkonten verlieren Geld beim CFD-Handel mit diesem Anbieter. Sie sollten überlegen, ob Sie es sich leisten können, das hohe Risiko einzugehen, Ihr Geld zu verlieren.
Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Indizes in diesem Artikel

NASDAQ Comp. 19 478,88 -0,06%